Skip to main content

Laboratory Glassware Market

“Laboratory Glassware Market, by Product [Glassware (Pipette, Flasks, Containers, Petri Dishes, Slides), Plasticware (Pipette, Laboratory Beakers, Racks, Storage boxes)], End user (Diagnostic center, Pharmaceuticals) – Forecast to 2020”

Factors such as increasing demand for plasticware owing to its cost-effectiveness, technological advancements, and introduction of specialty glassware are driving the growth of the laboratory glassware market. However, the brittle nature of glass (resulting in low preference for glassware) and lack of funds (resulting in fewer research activities, thus affecting both glassware and plasticware markets) are the major factors that are expected to restrain the growth of this market to a certain extent.

North America is expected to account for more than 40% of the laboratory glassware market in 2015. In this region, R&D studies make use of laboratory glassware and plasticware on a large scale, which is a major factor responsible for the large share of North America in this market. However, in the coming years, the Asia-Pacific market is expected to witness the highest growth owing to the rising outsourcing activities in research and manufacturing as a result of low costs and access to skilled labor in this region.

From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends); market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the laboratory glassware market; high-growth regions; and market drivers, restraints, and opportunities.

Download an Illustrative overview of the report:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=259374410

Companies in the laboratory glassware market are majorly focusing on expanding and entering segments for new indications and technologies. New product launch is the major strategy adopted by key market players to enhance their product offerings and increase their shares in the laboratory glassware and plasticware market. A number of market players also adopted the strategy of acquisitions, which accounted for a significant share of the total number of strategic developments undertaken by market players in recent years.

Thermo Fisher Scientific is one of the leading companies in the laboratory glassware market. The company primarily focuses on strengthening its R&D capabilities to continuously develop and market innovative products.
In January 2016, Thermo Fisher Scientific acquired Affymetrix, Inc. (U.S.), a leading provider of cellular and genetic analysis products. Affymetrix provides a wide range of laboratory products for pharmaceutical, biotechnology, and diagnostic applications, among others. With this, Thermo Fisher increased its geographic and commercial reach and strengthened its market presence.

Know more: https://www.marketsandmarkets.com/Market-Reports/laboratory-plasticware-laboratory-glassware-market-259374410.html

Comments

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...